Biopharmaceutics
PhysicochemicalPropertiesofDrugsAffectingBioavailability
Lec:4
Assist.LecturerAliYaseen AliBScPharmacy
MScIndustrialPharmaceuticalSciencesDept.ofPharmaceuticsSchoolofPharmacy
UniversityofSulaimani1
Biopharmaceutics
Physicochemicalproperties
DosageformRouteof
Administration
Bioavailability(Rate&Extent)
2
Overview• PhysicochemicalFactors– Dissolutionrate• DissolutionrateandNoyes-Whitneyequation• PhysiologicalFactorsaffectingDissolutionRate• DrugFactorsaffectingdissolutionrate• FactorsaffectingConcentrationintheGIT afterdissolving• Poorlysolubledrugs
– Dissociationofthedrugmolecules(pKa)• pH-partitionhypothesis
– Lipidsolubility–Molecularsizeandhydrogenbonding3
DissolutionRate
• Theprocessofdissolvingisdissolution• Thisprocesshasacertainrateovertimecalleddissolutionrate
4
• dm/dt:rateofdissolutionofdrugparticles• D:diffusioncoefficientofdruginsolutioninGITfluids• A:effectivesurfaceareaofthedrugparticlesincontact
withGITfluids• h: thicknessofthediffusionlayeraroundeachdrugparticle• Cs:isthesaturationsolubilityofthedruginsolutioninthe
GITfluids• C:theconcentrationofthedruginthegastrointestinal
fluids.
7
!"!#
=%&(()*(),
Overview• PhysicochemicalFactors
– Dissolutionrate• DissolutionrateandNoyes-Whitneyequation• PhysiologicalFactorsaffectingDissolutionRate• DrugFactorsaffectingdissolutionrate• FactorsaffectingConcentrationintheGIT afterdissolving• Poorlysolubledrugs
– Dissociationofthedrugmolecules(pKa)• pH-partitionhypothesis
– Lipidsolubility– Molecularsizeandhydrogenbonding
8
PhysiologicalFactorsaffectingDissolutionRate
• TheenvironmentofthegastrointestinaltractcanaffecttheparametersoftheNoyes-Whitneyequationandhencethedissolutionrateofadrug.
9
PhysiologicalFactorsaffectingDissolutionRate
• Thediffusioncoefficient,D,ofthedruginthegastrointestinalfluidsmaybedecreased bythepresenceofsubstancesthatincreasetheviscosityofthefluids.
10
!"!#
=%&(()*(),
FoodintheGIT
• Foodmaycauseadecreaseindissolutionrateofadrugbyreducingtherateofdiffusion ofthedrugmoleculesawayfromthediffusionlayersurroundingeachundissolved drugparticle.
11
!"!#
=%&(()*(),
Surfactants
• Surfactantsingastricjuiceandbilesalts–Wettability ofthedrug,andhencetheeffectivesurfacearea,A,exposedtogastrointestinalfluids
– solubilityofthedruginthegastrointestinalfluidsviamicellisation.
12
!"!#
=%&(()*(),
Motility
• Thethicknessofthediffusionlayer,h,willbeinfluencedbythedegreeofagitationexperiencedbyeachdrugparticleintheGIT.
– ThisiscanbeseenbytheGImotilitybothgastricandintestine.
13
!"!#
=%&(()*(),
Overview
• PhysicochemicalFactors– Dissolutionrate• DissolutionrateandNoyes-Whitneyequation• PhysiologicalFactorsaffectingDissolutionRate• DrugFactorsaffectingdissolutionrate• FactorsaffectingConcentrationintheGIT afterdissolving
– Dissociationofthedrugmolecules(pKa)– Lipidsolubility– Chemicalstabilityandcomplexationpotential
14
DrugFactorsaffectingdissolutionrate
1. Particlesize&wettability2. Solubility3. Formofthedrug
a) Saltorfreeb) Crystallineoramorphous
15
1.ParticlesizeandWetability• Surfaceareaisincreasedbyparticlesizereduction(micronisation )
• Increaseinthesurfaceareawillincreasetherateofdissolution• ProvidedthatalltheparticlesareintimatelywettedbyGITfluids
• Dissolutionratelimiteddrugs,particlesizereduction(increaseA)islikelytoincreasebioavailabilityofthedrug.
16
!"!#
=%&(()*(),
Example
• Griseofulvin:classicexampleofwhichparticlessizereductionincreasesitsbioavailability.
• Manypoorlysolubledrugsorslowlydissolvingdrugsarepresentedinmicronised formtoimprovetheirdissolutionprofile.
17
I.Hydrophobicdrugs:
• Micronisationmightresultinaggregationofparticlestoformbiggerparticleshencereducesurfacearea.
– E.g.Aspirin,Phenobarbitals
20
Solvingtheproblem
• Theproblemofaggregationcanbesolvedby:A. Micronisation inthepresenceofwetting
agentorhydrophiliccarrierA. E.g.danazol,bioavailabilityincreasedby400%
B. Additionofwettingagenttotheformulation– E.g.Polysorbate 80addedtoaqueous
suspensionofphenacetin,improvedrateandextentofabsorption.
21
II.Chemicaldegradation
Somedrugsareunstableinstomachacid.
– ErythromycinandPenG
• Particlesizereductionwillincreasetheirdissolutionrate
• Alsoincreases destructionofdrugs
22
DrugFactorsaffectingdissolutionrate
1. Particlesize&wettability2. Solubility3. Formofthedrug
a) Saltorfreeb) Crystallineoramorphous
23
IntrinsicSolubilityCs• UndersinkconditionsaccordingtotheNoyes-Whitneyequation,thedissolutionrate∝thesolubilityCs.
• Solubility– Molecularinteractionbetweenmoleculesofthesolidparticle– Intermolecularinteractionbetweenthemoleculesofthesolventandthesolidsubstance
– Entropychanges
Fordrugs(weakelecrtolytes)pHisalsoimportant.
dm/dt=DA(Cs-C)/h
24
sIntrinsicSolubilityC
• DissolutionratedependsonthepKa ofthedrugandthesolubilityinthediffusionlayer.
• pHofthediffusionlayerdependsonthepKa ofthedrugandsolubility,pKaandsolubilityofbuffersintheGIT
• DifferenceinthedissolutionrateisexpectedfromdifferentGITregions.
25
sIntrinsicSolubilityC
• Weakacids:solubilityincreaseswithincreasingpHdowntheGIT
• Weakbases:solubilitydecreaseswithincreasingpH– Thesesdrugsneedstobedissolvedinthestomachpriortothetransittotheintestine
– Ketoconazole given2hoursafterH2 antagonistcimetidine,resultsinthereductionintherateandextentofabsorption
26
DrugFactorsaffectingdissolutionrate
1. Particlesize&wettability2. Solubility3. Formofthedrug
a) Saltorfreeb) Crystallineoramorphous
27
Salts
• Thedissolutionofweakaciddrugsinthestomachisrelativelylow?
• Dissolutionofthesedrugscanbeincreased bychangingchemicalnatureofthedrugandmaketheminthesaltform,sodiumNa+ orpotassiumK+salts.
28
Precipitation
• HoweverwhenthedrugdiffusestothebulkpHprecipitation mightoccurwhentheconcentrationofthedrugishigherthanthesaturationconcentrationofthesolventtodissolveit.
31
Doestheprecipitationmatter?
• Theprecipitatesredissloveeasily– Veryfineparticlesandhighlywetted– Theconcentrationofthedruginthelumenreduces• Absorptionintothecirculation• Secretionandavailabilityofotherfluids• Emptyingintotheintestine
32
AcidicDrugs
• Strongbasicsaltsofweakacidsdrugs
• Tolbutamide sodium:hasdissolutionrate500timesfasterthanoffreeform,theabsorptionisfaster
• NaproxenNa
• BarbituratesaredesignedintheformofNasalttoproducefasteronsetofaction
33
Basicdrugs
• Drugstobedeliveredtotheabsorptionsiteinsolution
• Inordertoensurethatcompleteandfastdissolutionoccursinthestomach,drugismadeinthesaltform.
• Chorpromazine Cl dissolvesfaster inbothgastricandintestinalfluids
34
Crystalform• Whenadrugisfoundinmorethanonecrystallineformthisiscalledpolymorphism andeachofthecrystallineformsarecalledpolymorph.
• Tetracycline,chloramphencol palmitate
• Metastable formhasfasterdissolutionratethanmorestableforms.
• Fordissolutionlimiteddrugs,thismightaffectthebioavailabilityproducedbythedrug
35
Chloramphenicol
• Chloramphenicol palmitate:– A:stable– B:metastable– C:unstable
• Cistoounstabletobeusedindosageforms
• BhasfasterdissolutionratethanA,andhencetheextentofabsorptionishigher.
36
Solvates• Itistheabilitytoassociatewithsolventmoleculestomakecrystals.
• Solventiswater itiscalledhydrate.
• Thegreaterthesolvation ofthecrystalthe lowerthesolubilityanddissolutionrate inthesolventidenticaltothesolvation molecules.
• Thisdifferenceindissolutionmightreflectdifferencesinbioavailabilityofdissolutionlimiteddrugs.
37
Amorphoussolids• Dissolvesrapidly• Differencemightoccurinbioavailabilityofadrugthatisdissolutionratelimited.
• Stabilityissues
• OralsuspensionofNovobiocin:amorphousformiseffectivewhilethecrystallineformisineffective.
• Thisisbecauseofhedissolutionprofilebetweenthe2forms
• Theamorphousischangingtothecrystalline??
38
Amorphoussolids
• Theamorphousformofampicillinisfasterdissolving andhasgreaterextentofabsorptionthanampicillintrihydrate,inbothhardgelatinecapsulesandsuspensions.
39
Overview
• PhysicochemicalFactors– Dissolutionrate• DissolutionrateandNoyes-Whitneyequation• PhysiologicalFactorsaffectingDissolutionRate• DrugFactorsaffectingdissolutionrate• FactorsaffectingConcentrationintheGIT afterdissolving
– Dissociationofthedrugmolecules(pKa)– Lipidsolubility– Chemicalstabilityandcomplexationpotential
40
FactorsaffectingconcentrationofdruginsolutionintheGIT
PhysicochemicalpropertiesA. ComplexationB. Micellar solubilisationC. AdsorptionD. Chemicalstability
41
A.Complexation
• Beneficialordetrimental
• DosageformorGIT
• GITcomplexation :Tetracyclinewithfoodcomponents• Dosageforms:commoninliquiddosageforms– Presenceofcalciumasdiluent (dicalcium phosphate)inthedosageformsoftetracyclines reducesitsbioavailability
– PhenobarbitalandPEG4000
42
Beneficial
• Increasedrugsolubility,poorlywatersolubledrugs
• Cyclodextrinfamily:enzymaticallymodifiedstarch
43
b-cyclodextrin:hostplusguest
• Sevenunits• Outersurface–hydrophilic
• Innersurface–hydrophobic
• Increasesolubilityandhencebioavailability
44
• Miconazole :poorbioavailabilitybecauseofpoorwatersolubility
• Complexationenhancesitssolubilityanddissolutionrate
• Doublinginitsbioavailability• Itraconazole(Sporanox)thefirstdrugintheUK,piroxicamandindomethacin
45
C.Adsorption• Adsorbentscaninterfere withabsorptionofdrugsfromGIT.
• Foundasdrugsorintheformulationofdrugsandmedicines
• Kaolin,charcoal
• Reducetherateandextentofabsorptionthroughreducingtheeffectiveconcentrationofthedrugavailableforabsorption.
47
Reductionintherateorextent
• Dependsonthenatureofinteractionbetweenthedrugandadsorbent
• Reversible• Irreversible
e.g.lincomycin-kaopectate,promazine-charcoal
48
Stabilityissues
• Peptidedrugs
Solution1. Delayingthedissolutionofthedrug:enteric
coatingoftablets– Omeprazole,erythromycin
2. Prodrug:erythromycinstearate
50
Poorlysolubledrugs(DissolutionRateLimited)
1. Nanosizeion2. Formulationassolutionor,suspension3. Stabilisingdrugsinamorphousform4. Formulationwithcyclodextrin
52
Overview• PhysicochemicalFactors– Dissolutionrate• DissolutionrateandNoyes-Whitneyequation• PhysiologicalFactorsaffectingDissolutionRate• DrugFactorsaffectingdissolutionrate• FactorsaffectingConcentrationintheGIT afterdissolving• Poorlysolubledrugs
– Dissociationofthedrugmolecules(pKa)• pH-partitionhypothesis
– Lipidsolubility– Chemicalstabilityandcomplexationpotential53
DrugAbsorption
• Druginsolutionisreadyforabsorption
• Physicochemicalpropertiesaffectingabsorption:1. DissociationconstantpKa2. Lipophilicity(LogP)3. Molecularweight
54
Drugdissociationandlipidsolubility
1. Dissociationconstant2. Lipidsolubility3. pHoftheenvironmentintheGIT– alwaysaffectsabsorption
• TheinterrelationshipbetweendegreeofionisationofweakelectrolytedrugsintheGITandtheextentofabsorptionisexplainedbypH-partitionhypothesis.
55
pH-partitionhypotheis
• GITepitheliumactsasalipidbarrier todrugswhichareabsorbedbypassivediffusion.
• Lipidsoluble drugscanpassthemembrane.
• Mostdrugsareweakacidsandbases,theunionised offormofthedrugwillpassacrossthemembrane.
• However,themembraneisimpermeable totheionisedformofthedrugs.
56
• Absorption canbedeterminedbytheextentintowhichthedrugisfoundintheunionisedform.
• ThisisdeterminedbyHanderson-Hasselbalchequation.
57
Handerson-Hasselbalch• Weakacids:
𝑝𝐻 = 𝑝𝐾𝑎 + log[𝑖𝑜𝑛𝑖𝑠𝑒𝑑][𝑢𝑛𝑖𝑜𝑛𝑖𝑠𝑒𝑑]
– Weaklyacidicdrugs(pKa=3)willbepredominantlyunionisedatthestomachpH,andalmosttotallyionisedatintestinalpH.
• Weakbases
𝑝𝐻 = 𝑝𝐾𝑎 + log[𝑢𝑛𝑖𝑜𝑛𝑖𝑠𝑒𝑑][𝑖𝑜𝑛𝑖𝑠𝑒𝑑]
o Weaklybasic,pKa 5,almostentirelyionisedatgastricpH,andpredominantlyunionisedatintestinalpH.
58
Limitationsofhypothesis1. Degreeofionisationisnottheonlyfactorin
determiningabsorption.– Weakacidsalthoughareionisedintheintestine,theyarewellabsorbed.
– Therateofabsorptionintheintestineishigherthaninthestomach.• Largesurfacearea• Longresidencetime• MicroclimatepHontheepitheliumwhichislowerthanthelumen
59
2.Unstirredwaterlayerisnotaccountedfor3.Itcannotexplaintheabsorptionofsome
drugsthatareionisedacrosstheGIT.e.g.Quaternaryammoniumcompounds– Themembraneisnotcompletelyimpermeabletoioniseddrugs
– Itinteractswithendogenousoppositechargeionstoformabsorbableneutralspecies
60
Overview• PhysicochemicalFactors– Dissolutionrate• DissolutionrateandNoyes-Whitneyequation• PhysiologicalFactorsaffectingDissolutionRate• DrugFactorsaffectingdissolutionrate• FactorsaffectingConcentrationintheGIT afterdissolving• Poorlysolubledrugs
– Dissociationofthedrugmolecules(pKa)• pH-partitionhypothesis
– Lipidsolubility– Chemicalstabilityandcomplexationpotential61
Lipidsolubility
• TwodrugsmighthavesimilarpKa,accordingtothepH-partitionhypothesistheymustbeabsorbedinsimilarmanner.
• E.g.– Thiopentene (pKa:7.6)– Barbitone (pKa:7.8)– thiopentene isabsorbedbetter.• Becausethiopentene ismorelipophilic
62
Measurement
• Itiscalculatebymeasurementofitspartitionbetweenlipophilicsolventandwater,partitioncoefficient
63
Partitioncoefficient =[𝑐𝑜𝑛𝑐. 𝑖𝑛𝑜𝑟𝑔𝑎𝑛𝑖𝑐𝑝ℎ𝑎𝑠𝑒][𝑐𝑜𝑛𝑐. 𝑖𝑛𝑎𝑞𝑢𝑒𝑠𝑜𝑢𝑠𝑝ℎ𝑎𝑠𝑒]
Polarmolecules
• Polar(LogP <0)andlargemoleculescannotbeabsorbedandneedstobetakenbyotherroutes.– E.g.gentamicin,ceftriaxoneandheparin
• Polarmoleculeswithsmallersizecanbeabsorbedviaparacellular pathway.– E.g.Betablocker,Atenolol
64
• Lipid-solubledrugs(LogP>0)arewellabsorbedafteroraladministration.
• VeryLipid-solubledrugs(LogP>3)arewellabsorbed,buttheyaremorelikelytobemetabolisedandexcretedbybiliaryclearance.
• Althoughitisnotappliedtoalldrugs,butincreaseinlipophilicitywithinhomologousgroupimprovesabsorption– Beta-blockers
65
Molecularsizeandhydrogenbonding
• Paracelullarpathway.:– ideallymolecularweightshouldbe<200Dalton(therearealsoexamplesoflargermolecules)
• Transcellular(passivediffusion):–Molecularweightof<500ispreferable– Biggerthan500isabsorbedlessefficiently– Fewdrugsabsorbed>700
67
• Toomanyhydrogenbondsaredetrimental– Hydrogenbonddonors<5– Hydrogenbondacceptors<10
– the sum of nitrogen and oxygen atoms in the molecule is often taken as a rough measure of hydrogen bond acceptors
– Peptides
68
Conclusion
• Physicohcemicalpropertiesofthedrugaremajordeterminantofthedissolutionandabsorptionofdrugs.
• Therefore,rateandextentofabsorptionisinfluencedtolargeextent.
69